Document:

<PAGE>
                                                                   Exhibit 10.18

[AMICUS LOGO]
AMICUS
Therapeutics--------------------------------------------------------------------

May 12, 2006

Mr. Mark Simon
37 Kennedy Lane
Morristown NJ. 07960

Dear Mark:

         On behalf of Amicus Therapeutics, Inc. (the "Company"), I am pleased to
confirm our offer to you for the position of Senior Vice President Business
Development reporting to me. Your start date will be mutually agreed upon but no
later then June 12, 2006. With this offer you agree to devote no less then 30
hrs per week of your time and professional efforts to Amicus Therapeutics.

         Prior to the commencement of your employment you will be required to
execute the Company's Confidentiality, Disclosure and Non-Competition Agreement.
A copy of this agreement is attached. In addition, as a condition of employment
Amicus requires a pre-employment drug screening.

         In consideration for all your services to be rendered to the Company
your annual base salary will be $100,000, to be paid bi-weekly in accordance
with the Company's payroll practices. Upon the completion of mutually agreed
upon individual goals and objectives as well as the achievement of specific
Company goals, you will be eligible to receive a year end bonus target of 25% of
your base salary, prorated for your date of hire, minus customary deductions.

         Upon approval by the Board of Directors, you will receive an incentive
stock option to purchase 375,000 shares of the Company's common stock, par value
$.01 per share (the "Common Stock") pursuant to a stock option agreement in form
and substance acceptable to the Company. The options will become exercisable
over a four-year period as follows: 25% on the first anniversary of the date of
grant, and the remaining 75% in equal monthly increments thereafter. The
exercise price of the options will be the fair market value of the Company's
common stock on the date of grant. Shares issuable upon exercise of each option
will be subject to certain transfer restrictions including the right of first
refusal. Additionally, exercise of the options will be governed in accordance
with the provisions of the Company's stock option plan.

         You will be eligible to participate in the Company's health benefits
program and are eligible to participate in the Company's 401(k) as well as any
other employee benefit plan(s) that are generally made available by the Company
to its employees from time to time when and as the Company may make them
available.

--------------------------------------------------------------------------------
 6 Cedar Brook Drive   Cranbury, NJ 08512    T: 609-662-2000     F: 609-662-2001
                           www.amicustherapeutics.com
<PAGE>
Mr. Mark Simon
May 12, 2006
Page #2 of 3

         You will be eligible for paid Company holidays as outlined in our
Holiday Policy and you will be eligible for twenty (20) days paid vacation,
three weeks during the year and one between Christmas and New Years. Vacation
accrues on a monthly basis. Because the Company expects to regularly review its
benefit programs to keep them up to date and competitive, these programs are
subject to periodic adjustments so that certain features may be added, modified
or deleted over time.

         If you are terminated without Cause, you will be eligible for a
continuation of six (6) months salary, an additional six (6) months of option
vesting, plus payment of a bonus payment equal to the bonus earned in the
preceding year. "Cause" means for any of the following reasons: (i) willful or
deliberate misconduct by you that materially damages the company; (ii)
misappropriation of company assets; (iii) conviction of or a plea of guilty or
"no contest" to, a felony; or (iv) any willful disobedience of the lawful and
unambiguous instructions of the CEO of the company; provided that the CEO has
given you written notice of such disobedience or neglect and you have failed to
cure such disobedience or neglect within a period reasonable under the
circumstances.

         If there is a Change in Control Event and you resign for Good Reason or
are terminated without Cause within six months of such Change in Control Event,
then (i) you will be entitled to receive a continuation of twelve (12) months
salary, plus payment of a bonus payment equal to the bonus earned in the
preceding year and (ii) all unvested stock options will have their remaining
vesting schedule accelerated so that all stock options are fully vested.

         "Change in Control Event" means any of the following: (i) any person or
entity (except for a current stockholder) becomes the beneficial owner of
greater than 50% of the then outstanding voting power of the company; (ii) a
merger or consolidation with another entity where the voting securities of the
company outstanding immediately before the transaction constitute less than a
majority of the voting power of the voting securities of the company or the
surviving entity outstanding immediately after the transaction, or (iii) the
sales or disposition of all or substantially all of the company's assets. "Good
Reason" means (i) a change in your position with the company or its successor
that materially reduces your title, duties or level of responsibility; or (ii)
the relocation of the company or its successor greater than 50 miles away from
the then current location of the company's principal offices.

         Your right to receive accelerated vesting and severance payments
pursuant to the preceding three paragraphs shall be subject to the condition
that you execute a full release and waiver of all claims against the company and
related parties, in a form acceptable to the company.

         There is a two (2) year term on this agreement that will automatically
renew unless either party provides a thirty (30) day notice of termination.
<PAGE>

Mr. Mark Simon
May 12, 2006
Page #3 of 3

         In accordance with the Immigration and Naturalization Control Act, all
new employees must provide documentation that they have the legal right to work
in the United States. A copy of Form I-9 and a list of the acceptable documents
confirming your right to work in the United States are also attached for your
convenience.

         To indicate your acceptance of our offer, please sign one copy of this
letter in the space indicated below and return it to the attention of Nicole
Schaeffer, Vice President of Human Resources & Leadership Development by May 19,
2006. Acceptance of this offer constitutes your agreement with all of the above
terms and conditions of employment with Amicus Therapeutics, Inc., and
constitutes agreement to conform to Amicus Therapeutics, Inc. rules and
procedures. By signing below, you agree that no other promises, express or
implied, have been made to you either verbally or in writing and that no further
modifications to these terms and conditions will be effective except by a
written agreement signed by the Chief Executive Officer of the Company and you.

         The formality of this letter not withstanding, I extend my personal
best wishes and sincere pleasure that you are joining our team. I look forward
to working with you.

Sincerely,

/s/ John F. Crowley

John F. Crowley
President & CEO

I accept the offer of employment under the terms and conditions stated above. No
other promises, express or implied, have been made to me either verbally or in
writing.

By: /s/ Mark Simon                                 Date: 6/19/06
   -------------------------------------------         -------------------------
                  Mark SimonEX-10.1

 

EMPLOYMENT AGREEMENT

     EMPLOYMENT AGREEMENT dated as of March 26, 2007, by and between Cogdell Spencer Inc., a
Maryland corporation (the “REIT”), Cogdell Spencer LP, a Delaware Limited Partnership (the
“Operating Partnership”) each with its principal place of business at 4401 Barclay Downs Drive,
Suite 300, Charlotte, North Carolina 28209-4670, and Heidi Barringer, residing at the address set
forth on the signature page hereof (the “Executive”).

     WHEREAS, the REIT and the Operating Partnership (collectively, the “Company”) wish to employ
the Executive, and the Executive wishes to accept such offer, on the terms set forth below:

     Accordingly, the parties hereto agree as follows:

     1. Term. The Company hereby employs the Executive, and the Executive hereby accepts
such employment, for an initial term (the “Initial Term”) commencing on April 5, 2007 and
continuing for a three-year period, unless sooner terminated in accordance with the provisions of
Section 4 or Section 5; with such employment to continue for successive one-year periods in
accordance with the terms of this Agreement (subject to termination as aforesaid) unless either
party notifies the other party of non-renewal in writing prior to 90 days before the expiration of
the initial term and each annual renewal, as applicable (the Initial Term, together with any such extensions of employment hereunder, shall
hereinafter be referred to as the “Term”).

     2. Duties. During the Term, the Executive shall be employed by the Company as
Executive Vice President and, as such, the Executive shall faithfully perform for the Company the
duties of said office and shall perform such other duties of an executive, managerial or
administrative nature as shall be specified and designated from time to time by the CEO, Board of
Directors of the Company (the “Board”) or the General Partner of the Operating Partnership (the
“General Partner”) (including, without limitation, the performance of duties for affiliates and
subsidiaries of the Company). The Executive shall devote

 

 

substantially all of her business time
and effort to the performance of her duties hereunder; provided that, the following activities do
not interfere with the Executive’s ability to perform her duties hereunder, the Executive shall not
be prohibited from performing personal and charitable activities and engaging in any other business
interests as may be approved by the CEO, Board or the General Partner. Notwithstanding the
foregoing, unless otherwise consented to by the parties hereto, in the event of any termination of
employment with either the REIT or the Operating Partnership at a time when the REIT and the
Operating Partnership are affiliates, then such termination will be considered to be a termination
of such employment with the Company. Nothing herein shall restrict the ability of the Operating
Partnership from classifying the Executive as a non-employee service provider thereto for
tax-administrative purposes, for purposes of employee benefit plans and programs and for such other
purposes as it may deem appropriate.

     3. Compensation.

          3.1 Salary. The Company shall pay the Executive during the Term a salary at the rate
of $200,000 per annum (the “Annual Salary”), in accordance with the customary payroll practices of
the Company applicable to senior executives (or, if there is no such policy, such practices of the
Company’s principal affiliates). At least annually, the CEO, Board or the General Partner shall
review the Executive’s Annual Salary and may provide for increases therein as it may in its
discretion deem appropriate.

          3.2 Bonus. During the Term, in addition to the Annual Salary, for each fiscal year of
the Company ending during the Term, the Executive shall have the opportunity to receive an annual
bonus in an amount to be determined by the Company (the “Annual Bonus”).

          3.3 Benefits — In General. The Executive shall be permitted during the Term to
participate in, and the Company shall, to the extent permitted under the following plans and
programs, waive any waiting period with respect to, any group life, hospitalization or disability
insurance plans, health programs, equity-based plans, retirement plans, fringe benefit programs and
similar benefits that may be available to other senior executives of the Company generally, on the
same terms as such other

2

 

executives, in each case to the extent that the Executive is eligible
under the terms of such plans or programs.

          3.4 Expenses. The Company shall pay or reimburse the Executive for all ordinary and
reasonable out-of-pocket expenses actually incurred (and, in the case of reimbursement, paid) by
the Executive during the Term in the performance of the Executive’s services under this Agreement;
provided that the Executive submits proof of such expenses, with the properly completed forms as
prescribed from time to time by the Company.

          3.5. Certain Specific Benefits. The Company shall make available to the Executive,
vacation of 20 business days per year, including the fiscal year ending December 31, 2007, and an
appropriate Company car allowance consistent with car allowances for other senior executives.

     4. Termination upon Death or Disability. If the Executive dies during the Term, the
Term shall terminate as of the date of death, and the obligations of the Company to or with respect
to the Executive shall terminate in their entirety upon such date except as otherwise provided
under this Section 4. If the Executive by virtue of ill health or other disability is unable to
perform substantially and continuously the duties assigned to her for more than 180 consecutive or
non-consecutive days out of any consecutive 12-month period, the Company shall have the right, to
the extent permitted by law, to terminate the employment of the Executive upon notice in writing to
the Executive. Upon termination of employment due to death or disability, (i) the Executive (or
the Executive’s estate or beneficiaries in the
case of the death of the Executive) shall be entitled to receive any Annual Salary, Annual
Bonus (which Annual Bonus for the fiscal year ending December 31, 2007, for purposes of this
Section 4(i), shall accrue monthly at a rate of $8,333) and other benefits earned and accrued under
this Agreement prior to the date of termination (and reimbursement under this Agreement for
expenses incurred prior to the date of termination), (ii) all outstanding unvested equity-based
awards (including, without limitation, stock options and restricted stock) held by the Executive
shall fully vest and become immediately exercisable, as applicable, subject to the other terms of
such awards, and (iii) except as otherwise required under applicable law, the Executive (or, in the
event of her death, her estate and beneficiaries) shall have no

3

 

further rights to any other compensation or benefits hereunder on or after the termination of employment, or any other rights
hereunder.

     5. Certain Terminations of Employment.

          5.1 Termination by the Company for Cause; Termination by the Executive without Good
Reason.

          (a) For
purposes of this Agreement, “Cause” shall mean the
Executive’s:

          (i) conviction of, or formal admission to, a felony;

          (ii) engagement in the performance of her duties hereunder, or otherwise to the
material and demonstrable detriment of the Company, in willful misconduct, willful
or gross neglect, fraud, misappropriation or embezzlement;

          (iii) repeated failure to adhere to the directions of the CEO, Board or the General
Partner, or to adhere to the Company’s policies and practices;

          (iv) willful and continued failure to substantially perform her duties properly
assigned to her (other than any such failure resulting from her disability) after
demand for substantial performance is delivered by the Company specifically
identifying the manner in which the Company believes the Executive has not
substantially performed such duties;

          (v) breach of any of the provisions of Section 6; or

          (vi) breach in any material respect of the terms and provisions of this Agreement
and failure to cure such breach within 90 days following written notice from the
Company specifying such breach;

provided that the Company shall not be permitted to terminate the Executive for Cause except on
written notice given to the Executive at any time following the occurrence of any of the events
described in clauses (i), (ii) or (v) above and on written notice given to the Executive at any
time not more than 30 days following the occurrence of, or if later, the Company’s knowledge of,
any of the events described in clause (iii), (iv) or (vi) above. No termination for Cause shall be
effective unless the Board or the General Partner makes a Cause determination after notice to the
Executive and the Executive has been provided with the opportunity (with counsel of her choice) to
contest the determination at a meeting of the Board or with the board of trustees the General
Partner.

4

 

          (b) During the Term, the Company may terminate the Executive’s employment hereunder for Cause,
as provided above, and the Executive may terminate her employment without Good Reason on at least
30 days’ and not more than 60 days’ written notice given to the Company. If (i) the Company
terminates the Executive for Cause, or the Executive terminates her employment and the termination
by the Executive is not for Good Reason in accordance with Section 5.2 or covered by Section 5.3,
the Executive shall receive Annual Salary and other benefits (but, in all events, and without
increasing the Executive’s rights under any other provision hereof, excluding any bonuses not yet
paid) earned and accrued under this Agreement prior to the termination of employment (and
reimbursement under this Agreement for expenses incurred prior to the termination of employment);
and (ii) a termination occurs in accordance with this Section 5.1, except as otherwise required
under applicable law, the Executive shall have no further rights to any other compensation or
benefits hereunder on or after the termination of employment, or any other rights hereunder.

          5.2 Termination by the Company without Cause; Termination by the Executive for Good
Reason.

          (a) For purposes of this Agreement, “Good Reason” shall mean, unless otherwise consented to by
the Executive,

          (i) the material reduction of the Executive’s authority, duties and
responsibilities, or the assignment to the Executive of duties materially
inconsistent with the Executive’s position or positions with the Company;

          (ii) a reduction in Annual Salary of the Executive;

          (iii) the relocation of the Executive’s office to more than 50 miles from Charlotte,
North Carolina; or

          (iv) the Company’s material and willful breach of this Agreement.

Notwithstanding the foregoing, (A) Good Reason shall not be deemed to exist unless notice of
termination on account thereof (specifying a termination date no later than 30 days from the date
of such notice) is given no later than 90 days after the time at which the event or condition
purportedly giving rise to Good Reason first occurs or arises and (B) if there exists (without
regard to this clause (B)) an event or

5

 

condition that constitutes Good Reason, the Company shall
have 60 days from the date notice of such a termination is given to cure such event or condition
and, if the Company does so, such event or condition shall not constitute Good Reason hereunder.

          (b) During the Term, the Company may terminate the Executive’s employment at any time for any
reason or no reason and the Executive may terminate the Executive’s employment with the Company for
Good Reason. If the Company terminates the Executive’s employment and the termination is not
covered by Section 4, 5.1 or 5.3, or the Executive terminates her employment for Good Reason and
the termination by the Executive is not covered by Section 5.3, (i) the Executive shall receive
Annual Salary, Annual Bonus (which Annual Bonus for the fiscal year ending December 31, 2007, for
purposes of this Section 5.2(b)(i), shall accrue monthly at a rate of $8,333) and other benefits
earned and accrued under this Agreement prior to the termination of employment (and reimbursement
under this Agreement for expenses incurred prior to the termination of employment); (ii) the
Executive shall receive (A) a cash payment equal to 1.99 times the sum of (x) the Executive’s
Annual Salary (as in effect on the effective date of such termination) payable no later than 30
days after such termination and (y) the greater of (1) the average of the two previous Annual
Bonuses received by the Executive as provided for in Section 3.2, or (2) the maximum amount payable
under Section 3.2 for the fiscal year in which the termination occurs (the “Termination Bonus”),
or, in the event the Executive has not received any Annual Bonuses pursuant to Section 3.2 at the
time of such termination, the Termination Bonus shall be equal to
the Annual Bonus the Executive would have received under Section 3.2 if the Executive would
have remained employed through the period required to be entitled to receive the Annual Bonus and
satisfied all target performance objectives, payable no later than 30 days after such termination
(or, if later, as soon as practicable, but in no event more than 30 days after, the amount of the
Termination Bonus is known) and (B) for a period of three years after termination of employment
such continuing health benefits (including any medical, vision or dental benefits), under the
Company’s health plans and programs applicable to senior executives of the Company generally as the
Executive would have received under this Agreement (and at such costs to the Executive) as would
have applied in the absence of such termination

6

 

(but not taking into account any post-termination
increases in Annual Salary that may otherwise have occurred without regard to such termination and
that may have favorably affected such benefits); (iii) all outstanding unvested equity-based awards
held by the Executive shall vest and become immediately exercisable and shall otherwise become free
of restrictions and be exercisable in accordance with their terms and the Executive shall become
vested in any pension or other deferred compensation other than pension or deferred compensation
under a plan intended to be qualified under Section 401(a) or 403(a) of the Internal Revenue Code
of 1986, as amended; and (iv) except as otherwise required under applicable law, the Executive
shall have no further rights to any other compensation or benefits hereunder on or after the
termination of employment, or any other rights hereunder. To the extent that the Executive remains
employed with the Company subsequent to December 31, 2007, for purposes of Section 5.2(b)(ii)(y)
hereof, the Annual Bonus for the fiscal year ending December 31, 2007 shall be $100,000.

          (c) Notwithstanding clause (ii)(B) of the second sentence of Section 5.2(b), (i) nothing
herein shall restrict the ability of the Company to amend or terminate the plans and programs
referred to in such clause (ii)(B) from time to time in its sole discretion, but the Company may
not reduce benefits already earned and accrued by, but not yet paid to, the Executive and (ii) the
Company shall in no event be required to provide any benefits otherwise required by such clause
(ii)(B) after such time as the Executive becomes entitled to receive benefits of the same type from
another employer or recipient of the Executive’s services (such entitlement being determined without regard to any individual
waivers or other similar arrangements).

          5.3 Change of Control.

          (a) Without duplication of the foregoing, upon a “Change in Control” (as defined below) while
the Executive is employed, all outstanding unvested equity-based awards (including stock options
and restricted stock) shall fully vest and become immediately exercisable, as applicable. In
addition, if, after a Change in Control, the Executive terminates her employment with the Company
for any reason on or before the first anniversary of the Change in Control, such termination shall
be deemed a termination

7

 

by the Executive for Good Reason covered by Section 5.2, provided, that the
Executive provides no less than 30 days’ advance written notice to the Company.

          (b) For purposes of this Agreement, “Change in Control” shall have the same meaning as in the
Company 2005 Long Term Incentive Compensation Plan (or any successor plan thereof).

     6. Covenants of the Executive.

          6.1 Consideration. The Executive acknowledges, understands and agrees that, in
consideration for agreeing to and complying with the terms and conditions contained in this Section
6 hereof, she will be entitled to a lump sum payment, payable no later than 30 days after a
termination of the Executive’s employment under Section 5 of this Agreement, equal to the sum of
(i) the Executive’s Annual Salary for one year and (ii) the greater of (A) the average of the two
previous Annual Bonuses received by the Executive as provided for in Section 3.2, or (B) the
maximum amount payable under Section 3.2 for the fiscal year in which the termination occurs, or,
in the event the Executive has not received any Annual Bonuses pursuant to Section 3.2 at the time
of such termination, such Annual Bonus shall be equal to the Annual Bonus the Executive would have
received under Section 3.2 if the Executive would have remained employed through the period
required to be entitled to receive the Annual Bonus and satisfied all target performance
objectives. Notwithstanding the foregoing, within seven days of a termination of the Executive’s
employment under Section 5 of this Agreement, the Company may give
written notice to the Executive stating that it does not wish to enforce the terms and
conditions contained in this Section 6, and upon issuance of such notice, the Company will not be
obligated to pay and the Executive will not be entitled to receive any consideration under this
Section 6 and the covenants contained in this Section 6 will have no force and effect. To the
extent that the Executive remains employed with the Company subsequent to December 31, 2007, for
purposes of Section 6.1(ii) hereof, the Annual Bonus for the fiscal year ending December 31, 2007
shall be $100,000.

8

 

          6.2 Covenant Against Competition; Other Covenants. The Executive acknowledges that
(i) the principal business of the Company (which expressly includes for purposes of this Section 6
(and any related enforcement provisions hereof), its successors and assigns) is the ownership,
operation, development, redevelopment, acquisition and management of strategically located medical
office buildings and other healthcare related facilities (such business and any and all other
businesses that after the date hereof, and from time to time during the Term, become material with
respect to the Company’s then-overall business, herein being collectively referred to as the
“Business”); (ii) the Company is one of the limited number of persons who have developed such a
business; (iii) the Company’s Business is, in part, national in scope; (iv) the Executive’s work
for the Company has given and will continue to give her access to the confidential affairs and
proprietary information of the Company; (v) the covenants and agreements of the Executive contained
in this Section 6 are essential to the business and goodwill of the Company; and (vi) the Company
would not have entered into this Agreement but for the covenants and agreements set forth in this
Section 6. Accordingly, the Executive covenants and agrees that:

          (a) By and in consideration of the payments to be provided by the Company hereunder, and
further in consideration of the Executive’s exposure to the proprietary information of the Company,
the Executive covenants and agrees that, during the period commencing on the date hereof and ending
one year following the date upon which the Executive shall cease to be an employee of the Company
and its affiliates (the “Restricted Period”), she shall not directly or indirectly, whether as an
owner, partner, shareholder, principal, agent, employee, consultant or in any other relationship or
capacity, (i) engage in any element of the Business (other than for the Company or its
affiliates) or otherwise compete with the Company or its affiliates, (ii) render any services to
any person, corporation, partnership or other entity (other than the Company or its affiliates)
engaged in competition with the Company or its affiliates, or (iii) provide financial assistance to
or otherwise obtain an ownership interest in a competitor of the Company or its affiliates;
provided, however, that, notwithstanding the foregoing, the Executive may invest in securities of
any entity, solely for investment purposes and without participating in the business thereof, if
(A) such securities are traded on any national securities exchange

9

 

or the National Association of
Securities Dealers, Inc. Automated Quotation System, (B) the Executive is not a controlling person
of, or a member of a group which controls, such entity and (C) the Executive does not, directly or
indirectly, own 5% or more of any class of securities of such entity.

          (b) During and after the Restricted Period, the Executive shall keep secret and retain in
strictest confidence, and shall not use for her benefit or the benefit of others, except in
connection with the business and affairs of the Company and its affiliates, all confidential
matters relating to the Company’s Business and the business of any of its affiliates and to the
Company and any of its affiliates, learned by the Executive heretofore or hereafter directly or
indirectly from the Company or any of its affiliates (the “Confidential Company Information”), and
shall not disclose such Confidential Company Information to anyone outside of the Company except
with the Company’s express written consent and except for Confidential Company Information which is
at the time of receipt or thereafter becomes publicly known through no wrongful act of the
Executive or is received from a third party not under an obligation to keep such information
confidential and without breach of this Agreement.

          (c) During the Restricted Period, the Executive shall not, without the Company’s prior written
consent, directly or indirectly, knowingly (i) solicit or encourage to leave the employment or
other service of the Company, or any of its affiliates, any employee or independent contractor
thereof or (ii) hire (on behalf of the Executive or any other person or entity) any employee or
independent contractor who has left the employment or other service of the Company or any of its
affiliates within the one-year
period which follows the termination of such employee’s or independent contractor’s employment
or other service with the Company and its affiliates. From the date hereof through the end of the
two-year period commencing with the Executive’s termination of employment with the Company, the
Executive will not, whether for her own account or for the account of any other person, firm,
corporation or other business organization, intentionally interfere with the Company’s or any of
its affiliates’ relationship with, or endeavor to entice away from the Company or any of its
affiliates, any person who during the 12-month period prior to the Executive’s termination is or
was a customer or client of the Company or any of

10

 

its affiliates. While the Executive’s
non-compete obligations under Section 6.2(a) are in effect, the Executive shall not publish any
statement or make any statement under circumstances reasonably likely to become public that is
critical of the Company or any of its affiliates, or in any way adversely affecting or otherwise
maligning the Business or reputation of the Company or any of its affiliates.

          (d) All memoranda, notes, lists, records, property and any other tangible product and
documents (and all copies thereof), whether visually perceptible, machine-readable or otherwise,
made, produced or compiled by the Executive or made available to the Executive concerning the
business of the Company or its affiliates, (i) shall at all times be the property of the Company
(and, as applicable, any affiliates) and shall be delivered to the Company at any time upon its
request, and (ii) upon the Executive’s termination of employment, shall be immediately returned to
the Company.

          6.3 Rights and Remedies upon Breach.

          (a) The Executive acknowledges and agrees that any breach by her of any of the provisions of
Section 6.2 (the “Restrictive Covenants”) would result in irreparable injury and damage for which
money damages would not provide an adequate remedy. Therefore, if the Executive breaches, or
threatens to commit a breach of, any of the provisions of Section 6.2, the Company and its
affiliates, in addition to, and not in lieu of, any other rights and remedies available to the
Company and its affiliates under law or in equity (including, without limitation, the recovery of
damages); shall have the right and remedy to have the Restrictive Covenants specifically enforced
(without posting bond and without the need to prove damages) by any court having equity
jurisdiction, including, without limitation, the right to
an entry against the Executive of restraining orders and injunctions (preliminary, mandatory,
temporary and permanent) against violations, threatened or actual, and whether or not then
continuing, of such covenants.

          (b) The Executive agrees that in any action seeking specific performance or other equitable
relief, she will not assert or contend that any of the provisions of this Section 6 are
unreasonable or otherwise unenforceable. The existence of any claim or cause of action by the
Executive, whether

11

 

predicated on this Agreement or otherwise, shall not constitute a defense to the
enforcement of the Restrictive Covenants.

     7. Other Provisions.

          7.1 Severability. The Executive acknowledges and agrees that (i) she has had an
opportunity to seek advice of counsel in connection with this Agreement and (ii) the Restrictive
Covenants are reasonable in geographical and temporal scope and in all other respects. If it is
determined that any of the provisions of this Agreement, including, without limitation, any of the
Restrictive Covenants, or any part thereof, is invalid or unenforceable, the remainder of the
provisions of this Agreement shall not thereby be affected and shall be given full effect, without
regard to the invalid portions.

          7.2 Duration and Scope of Covenants. If any court or other decision-maker of
competent jurisdiction determines that any of the Executive’s covenants contained in this
Agreement, including, without limitation, any of the Restrictive Covenants, or any part thereof, is
unenforceable because of the duration or geographical scope of such provision, then, after such
determination has become final and unappealable, the duration or scope of such provision, as the
case may be, shall be reduced so that such provision becomes enforceable and, in its reduced form,
such provision shall then be enforceable and shall be enforced.

          7.3 Enforceability; Jurisdiction; Arbitration.

          (a) The Company and the Executive intend to and hereby confer jurisdiction to enforce the
Restrictive Covenants set forth in Section 6 upon the courts of any jurisdiction within the
geographical scope of the Restrictive Covenants. If the courts of any one or more of such
jurisdictions hold the Restrictive Covenants wholly unenforceable by reason of breadth of scope or
otherwise it is the intention of the Company and the Executive that such determination not bar or
in any way affect the Company’s right, or the right of any of its affiliates, to the relief
provided above in the courts of any other jurisdiction within the geographical scope of such
Restrictive Covenants, as to breaches of such Restrictive Covenants in such other respective
jurisdictions, such Restrictive Covenants as they relate to

12

 

each jurisdiction’s being, for this
purpose, severable, diverse and independent covenants, subject, where appropriate, to the doctrine
of res judicata. The parties hereby agree to waive any right to a trial by jury
for any and all disputes hereunder (whether or not relating to the Restricted Covenants).

          (b) Any controversy or claim arising out of or relating to this Agreement or the breach of
this Agreement (other than a controversy or claim arising under Section 6, to the extent necessary
for the Company (or its affiliates, where applicable) to avail itself of the rights and remedies
referred to in Section 6.3) that is not resolved by the Executive and the Company (or its
affiliates, where applicable) shall be submitted to arbitration in Charlotte, North Carolina in
accordance with North Carolina law and the procedures of the American Arbitration Association. The
determination of the arbitrator(s) shall be conclusive and binding on the Company (or its
affiliates, where applicable) and the Executive and judgment may be entered on the arbitrator(s)’
award in any court having jurisdiction.

          7.4 Notices. Any notice or other communication required or permitted hereunder shall
be in writing and shall be delivered personally, telegraphed, telexed, sent by facsimile
transmission or sent by certified, registered or express mail, postage prepaid. Any such notice
shall be deemed given when so delivered personally, telegraphed, telexed or sent by facsimile
transmission or, if mailed, five days after the date of deposit in the United States mails as
follows:

	 	 	 	 	 
	 

	 	(i)
	 	If to the Company, to:
	 
	 	 	 	 
	 

	 	 	 	Cogdell Spencer Inc.
	 

	 	 	 	4401 Barclay Downs Drive, Suite 300
	 

	 	 	 	Charlotte, North Carolina 28209-4670
	 

	 	 	 	Attention: Frank C. Spencer
	 
	 	 	 	 
	 

	 	 	 	with a copy to:
	 

	 	 	 	Clifford Chance US LLP
	 

	 	 	 	31 West 52 Street
	 

	 	 	 	New York, New York 10019
	 

	 	 	 	Attention: Jay Bernstein
	 
	 	 	 	 
	 

	 	(ii)
	 	If to the Executive, to:
	 
	 	 	 	 
	 

	 	 	 	Heidi Barringer
	 

	 	 	 	[at the address set forth on the signature page hereof]

13

 

Any such person may by notice given in accordance with this Section 7.4 to the other parties hereto
designate another address or person for receipt by such person of notices hereunder.

          7.5 Entire Agreement. This Agreement contains the entire agreement between the
parties with respect to the subject matter hereof and supersedes all prior agreements, written or
oral, with respect thereto.

          7.6 Waivers and Amendments. This Agreement may be amended, superseded, canceled,
renewed or extended, and the terms hereof may be waived, only by a written instrument signed by the
parties or, in the case of a waiver, by the party waiving compliance. No delay on the part of any
party in exercising any right, power or privilege hereunder shall operate as a waiver thereof, nor
shall any waiver on the part of any party of any such right, power or privilege nor any single or
partial exercise of any such right, power or privilege, preclude any other or further exercise
thereof or the exercise of any other such right, power or privilege.

          7.7 GOVERNING LAW. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE
WITH THE LAWS OF THE STATE OF NORTH CAROLINA WITHOUT REGARD TO PRINCIPLES OF CONFLICTS OF LAW WHICH
COULD CAUSE THE APPLICATION OF THE LAWS OF ANY JURISDICTION OTHER THAN THE STATE OF NORTH CAROLINA.

          7.8 Assignment. This Agreement, and the Executive’s rights and obligations hereunder,
may not be assigned by the Executive; any purported assignment by the Executive in violation hereof
shall be null and void. In the event of any sale, transfer or other disposition of all or
substantially
all of the Company’s assets or business, whether by merger, consolidation or otherwise, the
Company may assign this Agreement and its rights hereunder.

          7.9 Withholding. The Company shall be entitled to withhold from any payments or
deemed payments any amount of tax withholding it determines to be required by law.

          7.10 No Duty to Mitigate. Except as may be provided in Section 5.2(c)(ii), the
Executive shall not be required to mitigate damages or the amount of any payment provided for under
this

14

 

Agreement by seeking other employment or otherwise, nor will any payments hereunder be subject
to offset in the event the Executive does mitigate.

          7.11 Binding Effect. This Agreement shall be binding upon and inure to the benefit of
the parties and their respective successors, permitted assigns, heirs, executors and legal
representatives.

          7.12 Counterparts. This Agreement may be executed by the parties hereto in separate
counterparts, each of which when so executed and delivered shall be an original but all such
counterparts together shall constitute one and the same instrument. Each counterpart may consist
of two copies hereof each signed by one of the parties hereto.

          7.13 Survival. Anything contained in this Agreement to the contrary notwithstanding,
the provisions of Sections 6, 7.3 and 7.9, and the other provisions of this Section 7 (to the
extent necessary to effectuate the survival of Sections 6, 7.3 and 7.9), shall survive termination
of this Agreement and any termination of the Executive’s employment hereunder.

          7.14 Existing Agreements. The Executive represents to the Company that she is not
subject or a party to any employment or consulting agreement, non-competition covenant or other
agreement, covenant or understanding which might prohibit her from executing this Agreement or
limit her ability to fulfill her responsibilities hereunder.

          7.15 Headings. The headings in this Agreement are for reference only and shall not
affect the interpretation of this Agreement.

          7.16 Parachutes. If any amount payable to or other benefit receivable by the Executive
pursuant to this Agreement is deemed to constitute a Parachute Payment (as defined below),
alone or when added to any other amount payable or paid to or other benefit receivable or
received by the Executive which is deemed to constitute a Parachute Payment (whether or not under
an existing plan, arrangement or other agreement), and would result in the imposition on the
Executive of an excise tax under Section 4999 of the Internal Revenue Code of 1986, as amended (the
“Code”), then, in addition to any other benefits to which the Executive is entitled under this
Agreement, the Executive shall be paid by the Company an amount in cash equal to the sum of the
excise taxes payable by the Executive by reason

15

 

of receiving Parachute Payments plus the amount
necessary to put the Executive in the same after-tax position (taking into account any and all
applicable federal, state and local excise, income or other taxes at the highest applicable rates
on such Parachute Payments and on any payments under this Section 7.16) as if no excise taxes had
been imposed with respect to Parachute Payments. “Parachute Payment” shall mean a “parachute
payment” as defined in Section 280G of the Code. The amount of any payment under this Section 7.16
shall be computed by a certified public accounting firm selected by the Company and reasonably
acceptable to the Executive.

[remainder of the page left intentionally blank]

16

 

     IN WITNESS WHEREOF, the parties hereto have signed their names as of the day and year first
above written.

	 	 	 	 	 	 	 
	 	 	COGDELL SPENCER INC.
	 
	 	 	 	 	 	 
	 

	 	By:	 	/s/ Frank C. Spencer	 	 
	 

	 	 	 	 

	 	 
	 

	 	Name:	 	Frank C. Spencer	 	 
	 

	 	 	 	 

	 	 
	 

	 	Title:	 	Chief Executive Officer and
President	 	 
	 

	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	 
	 	 	 	 	 	 

	 	 	 	 	 	 	 
	 	 	COGDELL SPENCER LP
	 
	 	 	 	 	 	 
	 

	 	By:	 	CS Business Trust I, its General
Partner	 	 
	 
	 	 	 	 	 	 
	 

	 	By:	 	/s/ Frank C. Spencer	 	 
	 

	 	 	 	 

	 	 
	 

	 	Name:	 	Frank C. Spencer	 	 
	 

	 	 	 	 

	 	 
	 

	 	Title:	 	Trustee	 	 
	 

	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	 
	 	 	 	 	 	 

	 	 	 	 	 	 	 
	 	 	HEIDI BARRINGER
	 
	 	 	 	 	 	 
	 

	 	By:	 	/s/ Heidi Barringer	 	 
	 

	 	 	 	 

	 	 
	 

	 	Name:	 	Heidi Barringer	 	 

17

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00120-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00120-of-00352.parquet"}]]